查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571641

核医设备市场规模、份额、趋势分析报告：2024-2030年按类型、应用、最终用途、地区和细分市场预测

Nuclear Medicine Equipment Market Size, Share & Trends Analysis Report By Type (SPECT, PET, Planar Scintigraphy Systems), By Application (Oncology, Cardiology, Neurology, General Imaging), By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

核医设备市场成长及趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球核医设备市场规模将达到84.7亿美元，2024年至2030年复合年增长率为3.1%。

核子医学利用放射线来诊断和治疗疾病。它还包括确定某些器官是否正常运作。在过去的二十年里，核子医学技术的快速进步彻底改变了医疗实务。

随着人们对慢性病早期诊断重要性的认识不断提高，核医学诊断检测在世界各地显着增加。这从占世界人口约26%的新兴国家的统计数据中可以清楚看出。这些国家每年进行核子医学诊断检测的比例为 1.9%。此外，在美国等已开发国家，每年核医检查的次数约2,000万次。很明显，诊断中核医和含放射性药物程序的使用频率正以每年 10% 以上的速度增加，这表明全世界越来越多地采用核医设备。然而，与核子医学设备相关的高成本和放射学报销支援不足预计将阻碍市场成长。此外，购买再製造系统以降低成本的趋势日益明显，预计将影响现有市场参与者的设备销售。

核子医学设备市场报告亮点

  • 由于慢性病诊断越来越偏好SPECT 和 PET 扫描，北美市场预计将出现良好的成长。
  • 北美地区对放射性药物使用的认识不断提高以及政府采取的倡议预计将推动使用率的提高。例如，2016年12月，FDA发布了新指南，以实施FDA提出的有关美国人体放射性药物的配製和重新包装的政策。
  • 在2023年的市场区隔中，由于全球癌症发生率和盛行率不断上升，肿瘤学在应用领域占据最大的市场占有率。
  • 在日本、中国和印度的推动下，亚太市场预计将出现显着成长，这些地区核子医学的使用正在迅速增加。此外，利用基于放射免疫疗法的标靶癌症治疗来降低癌症和心血管疾病的发生率正在推动市场成长。
  • 主要参与者正在关注新兴经济体的扩张和渗透机会，以实现市场的永续成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章全球核子医学设备市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 全球核子医学设备市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 全球核子医学设备市场：类型估计与趋势分析

  • 细分仪表板
  • 核子医学设备市场：2023年及2030年类型变化分析
  • SPECT
  • PET
  • 平面闪烁闪烁图术系统

第五章 全球核医设备市场：应用预估及趋势分析

  • 细分仪表板
  • 核子医学设备市场：2023年及2030年应用变化分析
  • 肿瘤学
  • 心臟病学
  • 神经病学
  • 常见影像

第六章 全球核子医学设备市场：最终用途估计与趋势分析

  • 细分仪表板
  • 核子医学设备市场：2023 年和 2030 年最终用途变化分析
  • 医院
  • 影像诊断中心
  • 其他用途

第七章全球核子医学设备市场：区域估计与趋势分析

  • 核医设备市场占有率（按地区），2023 年和 2030 年，十亿美元
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • GE HealthCare
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • CANON MEDICAL SYSTEMS CORPORATION
    • TTG IMAGING SOLUTIONS
    • Mediso Ltd.
    • CMR Naviscan
    • Neusoft Corporation.
    • Shenzhen Anke High-tech Co., Ltd.
    • Bracco Imaging SpA
    • Biosensors International Group, Ltd.
简介目录
Product Code: GVR-1-68038-413-0

Nuclear Medicine Equipment Market Growth & Trends:

The global nuclear medicine equipment market size is expected to reach a value of USD 8.47 billion by 2030 and is projected to grow at a CAGR of 3.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Nuclear medicine involves the utilization of radiation to diagnose diseases or treat them. It also involves determining whether specific organs are functioning normally. Over a stretch of the last two decades, rapid technological advancements in nuclear medicine have transformed the medicine practice.

With growing awareness about the importance of early diagnosis of chronic diseases, there has been a noticeable increase in diagnostic nuclear medicine procedures worldwide. This is evident from stats generated from developing countries, which represents about 26% of the world population. These countries conduct diagnostic nuclear medicine tests at a rate of 1.9% per year. In addition, in developed countries such as the U.S., the frequency of nuclear medicine procedures ranges to about 20 million per year. It is evident that the frequency of use of nuclear medicine and procedures involving radiopharmaceuticals in diagnosis is growing at over 10% per year, indicating a rise in adoption of nuclear medicine equipment worldwide. However, high cost associated with nuclear medicine equipment and insufficient reimbursement support for radiology is expected to hinder the growth of the market. In addition, a growing trend of purchasing refurbished systems for cost saving is expected to affect equipment sales of existing market players.

Nuclear Medicine Equipment Market Report Highlights:

  • The North American market is expected to register lucrative growth owing to increasing preference for SPECT and PET scans for diagnosis of chronic diseases
  • Growing awareness and government initiatives pertaining to usage of radiopharmaceuticals in the North American region is expected to boost usage rates. For instance, in December 2016, the FDA issued new guidelines to enforce FDA's proposed policies regarding compounding and repackaging of radiopharmaceuticals for human use in the U.S.
  • Oncology accounted for the largest market share in application segment in the year 2023 owing to the increasing incidence and prevalence of cancer worldwid
  • Asia Pacific market is expected to witness significant growth owing to Japan, China, and India where use of nuclear medicine is increasing at a fast pace. In addition, the usage of radioimmunotherapy-based targeted cancer treatment to counter incidence of cancer and cardiovascular diseases is aiding in the growth of the market
  • The key players are focused on expansion & penetration opportunities in developing and emerging economies to achieve sustainable growth in the market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Nuclear Medicine Equipment Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Global Nuclear Medicine Equipment Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Global Nuclear Medicine Equipment Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Nuclear Medicine Equipment Market: Type Movement Analysis, 2023 & 2030 (USD Billion)
  • 4.3. SPECT
    • 4.3.1. SPECT Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. PET
    • 4.4.1. PET Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Planar Scintigraphy Systems
    • 4.5.1. Planar Scintigraphy Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Global Nuclear Medicine Equipment Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Nuclear Medicine Equipment Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
  • 5.3. Oncology
    • 5.3.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Cardiology
    • 5.4.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Neurology
    • 5.5.1. Neurology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. General Imaging
    • 5.6.1. General Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Globe Nuclear Medicine Equipment Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Nuclear Medicine Equipment Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Diagnostic Imaging Centers
    • 6.4.1. Diagnostic Imaging Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Other End Use
    • 6.5.1. Other End Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Globe Nuclear Medicine Equipment Market: Regional Estimates & Trend Analysis

  • 7.1. Nuclear Medicine Equipment Market Share, By Region, 2023 & 2030, USD Billion
  • 7.2. North America
    • 7.2.1. North America Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.K.
      • 7.3.2.1. U.K. Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Italy
      • 7.3.4.1. Italy Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Spain
      • 7.3.5.1. Spain Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Denmark
      • 7.3.6.1. Denmark Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Sweden
      • 7.3.7.1. Sweden Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Norway
      • 7.3.8.1. Norway Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. GE HealthCare
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Siemens Healthineers AG
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Koninklijke Philips N.V.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. CANON MEDICAL SYSTEMS CORPORATION
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. TTG IMAGING SOLUTIONS
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Mediso Ltd.
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. CMR Naviscan
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Neusoft Corporation.
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Shenzhen Anke High-tech Co., Ltd.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Bracco Imaging S.p.A.
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives
    • 8.4.11. Biosensors International Group, Ltd.
      • 8.4.11.1. Participant's Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Recent Developments/ Strategic Initiatives